Strongbridge Biopharma plc.
SBBP
SBBP was delisted on the 5th of October, 2021.
58 hedge funds and large institutions have $87.2M invested in Strongbridge Biopharma plc. in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 19 increasing their positions, 17 reducing their positions, and 12 closing their positions.
300% more call options, than puts
Call options by funds: $8K | Put options by funds: $2K
58% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 12
14% more funds holding
Funds holding: 51 → 58 (+7)
12% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 17
36% less capital invested
Capital invested by funds: $135M → $87.2M (-$48M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.24M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
+$5.92M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.78M |
| 4 |
2L
22NW LP
Seattle,
Washington
|
+$1.47M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$955K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$4.74M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$4.58M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
-$4.55M |
| 4 |
AC
Armistice Capital
New York
|
-$3.35M |
| 5 |
BC
Broadfin Capital
New York
|
-$908K |
SBBP Hedge Fund Activity: Q2 2019 in Review
58 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Strongbridge Biopharma plc. (SBBP) for Q2 2019, worth a combined $87.2M — down 36% from $135M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new SBBP positions and 12 closed out — a net gain of 7 holders — while 19 added to existing stakes and 17 trimmed.
The largest buyer was BlackRock, adding an estimated $6.24M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $4.74M sold.
- 58 institutional investors held Strongbridge Biopharma plc. (SBBP) as of Q2 2019, up from 51 in Q1 2019.
- Funds reported $87.2M of Strongbridge Biopharma plc. stock for Q2 2019, down 36% quarter-over-quarter.
- 19 funds opened new Strongbridge Biopharma plc. positions in Q2 2019 and 12 closed out, a net change of +7 holders.
- The largest Strongbridge Biopharma plc. buyer in Q2 2019 was BlackRock, an estimated $6.24M added.
- The largest Strongbridge Biopharma plc. seller in Q2 2019 was Sphera Funds Management, an estimated $4.74M sold.
Based on aggregated 13F filings for Q2 2019.